A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure
Clinical Trial Grant
Awarded By
Salubris Biotherapeutics, Inc. (SalubrisBio)
Start Date
December 16, 2024
End Date
December 31, 2027
Awarded By
Salubris Biotherapeutics, Inc. (SalubrisBio)
Start Date
December 16, 2024
End Date
December 31, 2027